Incidental uptake of ¹⁸F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer

1. Balogova S, Kobetz A, Huchet V, Michaud L, Kerrou K, Paycha F, et al. Evolution of the prescription of nuclear medicine examinations in prostate cancer since the registration of fluorocholine (18F): a two-year survey at hospital Tenon. Med Nucl 2012; 36: 363-70.Search in Google Scholar

2. Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, et al. [18F] fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006; 33: 1387-98.10.1007/s00259-006-0150-216865395Search in Google Scholar

3. Treglia G, Giovannini E, Di Franco D, Calcagni ML, Rufini V, Picchio M, et al. The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review. Ann Nucl Med 2012; 26: 451-61.10.1007/s12149-012-0602-722566040Search in Google Scholar

4. Hodolič M, Fettich J, Cimitan M, Kragelj B, Goldsmith SJ. Unusual F-18 choline uptake in penile metastasis from prostate cancer. Clin Nucl Med 2012; 37: e89-90.10.1097/RLU.0b013e318248531122391732Search in Google Scholar

5. Schillaci O, Calabria F, Tavolozza M, Cicciò C, Carlani M, Caracciolo CR, et al. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer. Nucl Med Commun 2010; 31: 39-45.10.1097/MNM.0b013e328330adc519972635Search in Google Scholar

6. Balogova S, Nataf V, Gutman F, Huchet V, Kerrou K, Pascal O, et al. Biological recurrence of prostate cancer: Interest of whole-body fluorocholine (18F) PET/CT. Med Nucl 2010; 34: 540-5.Search in Google Scholar

7. Mertens K, Ham H, Deblaere K, Kalala JP, Van den Broecke C, Slaets D, et al. Distribution patterns of 18F-labelled fluoromethylcholine in normal structures and tumors of the head: a PET/MRI evaluation. Clin Nucl Med 2012; 37: e196-203.10.1097/RLU.0b013e31824c5dd022785527Search in Google Scholar

8. Jeong SY, Lee SW, Lee HJ, Kang S, Seo JH, Chun KA, et al. Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study. Eur J Nucl Med Mol Imaging 2010; 37: 2334-43.10.1007/s00259-010-1571-520661556Search in Google Scholar

9. Hyun SH, Choi JY, Lee KH, Choe YS, Kim BT. Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria. J Nucl Med 2011; 52: 547-50.10.2967/jnumed.110.08373321421711Search in Google Scholar

10. De Souza B, Brunetti A, Fulham MJ, Brooks RA, DeMichele D, Cook P et al. Pituitary microadenomas: a PET study. Radiology 1990; 177: 39-44.10.1148/radiology.177.1.23993362399336Search in Google Scholar

11. Daemen BJ, Zwertbroek R, Elsinga PH, Paans AM, Doorenbos H, Vaalburg W. PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment. Eur J Nucl Med 1991; 18: 453-60.10.1007/BF001812831915472Search in Google Scholar

12. Bergström M, Muhr C, Lundberg PO, Långström B. PET as a tool in the clinical evaluation of pituitary adenomas. J Nucl Med 1991; 32: 10-5.Search in Google Scholar

13. Tang BN, Levivier M, Heureux M, Wikler D, Massager N, Devriendt D et al. 11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas. Eur J Nucl Med Mol Imaging 2006; 33: 169-78.10.1007/s00259-005-1882-016228237Search in Google Scholar

14. Muhr C. Positron emission tomography in acromegaly and other pituitary adenoma patients. Neuroendocrinology 2006; 83: 205-10.10.1159/00009552917047384Search in Google Scholar

15. Naswa N, Das CJ, Sharma P, Karunanithi S, Bal C, Kumar R. Ectopic pituitary adenoma with empty sella in the setting of MEN-1 syndrome detection with 68Ga-DOTANOC PET/CT. Jpn J Radiol 2012; 30: 783-6.10.1007/s11604-012-0117-022923184Search in Google Scholar

16. Veit JA, Boehm B, Luster M, Scheuerle A, Rotter N, Rettinger G, et al. Detection of paranasal ectopic adrenocorticotropic hormone-secreting pituitary adenoma by Ga-68-DOTANOC positron-emission tomographycomputed tomography. Laryngoscope 2013; 123: 1132-5.10.1002/lary.2386723299948Search in Google Scholar

17. Mertens K, Bolcaen J, Ham H, Deblaere K, Van den Broecke C, Boterberg T, et al. The optimal timing for imaging brain tumours and other brain lesions with 18F-labelled fluoromethylcholine: a dynamic positron emission tomography study. Nucl Med Commun 2012; 33: 954-9.10.1097/MNM.0b013e328355b6f522842224Search in Google Scholar

18. Giovacchini G, Fallanca F, Landoni C, Gianolli L, Picozzi P, Attuati L, et al. C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: an initial experience. Clin Nucl Med 2009; 34: 7-10.10.1097/RLU.0b013e31818f436919092373Search in Google Scholar

19. Liu RS, Chang CP, Guo WY, Pan DH, Ho DM, Chang CW, et al. 1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery. J Nucl Med 2010; 51: 883-91.10.2967/jnumed.109.07056520484430Search in Google Scholar

20. Xiangsong Z, Xingchong S, Chang Y, Xiaoyan W, Zhifeng C. 13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report. Clin Nucl Med 2011; 36: 1003-6.10.1097/RLU.0b013e3182291c2a21975388Search in Google Scholar

21. Astner ST, Dobrei-Ciuchendea M, Essler M, Bundschuh RA, Sai H, Schwaiger M, et al. Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 2008; 72: 1161-7.10.1016/j.ijrobp.2008.02.05818440729Search in Google Scholar

22. Rutten I, Cabay JE, Withofs N, Lemaire C, Aerts J, Baart V, et al. PET/CT of skull base meningiomas using 2-18F-fluoro-L-tyrosine: initial report. J Nucl Med 2007; 48: 720-5.10.2967/jnumed.106.03821617475959Search in Google Scholar

23. González-Forero M, Prieto E, Domínguez I, Vigil C, Peñuelas I, Arbizu J. Dual time point 18F-FDOPA PET as a tool for characterizing brain tumors. Rev Esp Med Nucl 2011; 30: 88-93.10.1016/j.remn.2010.11.00721334774Search in Google Scholar

24. Afshar-Oromieh A, Giesel FL, Linhart HG, Haberkorn U, Haufe S, Combs SE, et al.. Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET/CT and contrast-enhanced MRI. Eur J Nucl Med Mol Imaging 2012; 39: 1409-15.10.1007/s00259-012-2155-322669255Search in Google Scholar

25. Mapelli P, Busnardo E, Magnani P, Freschi M, Picchio M, Gianolli L, et al. Incidental finding of parathyroid adenoma with 11C-choline PET/CT. Clin Nucl Med 2012; 37: 593-5.10.1097/RLU.0b013e31824c5ffc22614195Search in Google Scholar

26. Mendoza PL, Ongkeko EE, Santiago JF. Silent parathyroid adenoma mistakenly interpreted on FDG-PET as thyroid cancer metastasis in a patient with elevated thyroglobulin and negative I-131 whole body scan and removed by radioguided minimally invasive surgery. Clin Nucl Med 2008; 33: 23-5.10.1097/RLU.0b013e31815c50c018097251Search in Google Scholar

27. Kim MK, Kim GS, Kim SY, Baek KH, Kang MI, Lee KW, et al. F-18 FDG-avid intrathyroidal parathyroid adenoma mimicking follicular neoplasm. Clin Nucl Med 2009; 34: 178-9.10.1097/RLU.0b013e318196758c19352286Search in Google Scholar

28. Evangelista L, Sorgato N, Torresan F, Boschin IM, Pennelli G, Saladini G, et al. FDG-PET/CT and parathyroid carcinoma: Review of literature and illustrative case series. World J Clin Oncol 2011; 2: 348-54.10.5306/wjco.v2.i10.348319132722022662Search in Google Scholar

29. Sisson JC, Thompson NW, Ackerman RJ, Wahl RL. Use of 2-[F-18]-fluoro-2- deoxy-D-glucose PET to locate parathyroid adenomas in primary hyperparathyroidism. Radiology 1994; 192: 280.10.1148/radiology.192.1.82089558208955Search in Google Scholar

30. Melon P, Luxen A, Hamoir E, Meurisse M. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur J Nucl Med 1995; 22: 556-8.10.1007/BF008172827556303Search in Google Scholar

31. Neumann DR, Esselstyn CB, Maclntyre WJ, Go RT, Obuchowski NA, Chen EQ, Licata AA. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med 1996; 37: 1809-15.Search in Google Scholar

32. Caldarella C, Treglia G, Isgrò MA, Giordano A. Diagnostic performance of positron emission tomography using 11C-methionine in patients with suspected parathyroid adenoma: a meta-analysis. Endocrine 2013; 43: 78-83.10.1007/s12020-012-9746-422801990Search in Google Scholar

33. García Vicente AM, Núñez García A, Soriano Castrejón AM, Jiménez Londoño GA, Cordero García JM, Palomar Muñoz A. Pitfalls with 18F-choline PET/CT in patients with prostate cancer. Rev Esp Med Nucl Imagen Mol 2013; 32: 37-9.10.1016/j.remnie.2012.11.010Search in Google Scholar

34. Treglia G, Giovannini E, Mirk P, Di Franco D, Oragano L, Bertagna F. A thyroid Incidentaloma detected by 18F-Choline PET/CT. Clin Nucl Med 2014; 39(4): e267-9..10.1097/RLU.0b013e3182817d7823579984Search in Google Scholar

35. Yang Z, Shi W, Zhu B, Hu S, Zhang Y, Wang M, et al. Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. J Otolaryngol Head Neck Surg 2012; 41: 327-33.Search in Google Scholar

36. Bertagna F, Treglia G, Piccardo A, Giovannini E, Bosio G, Biasiotto G, et al. F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value. Endocrine 2013; 43: 678-85.10.1007/s12020-012-9837-223179777Search in Google Scholar

37. Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid 2012; 22: 918-25.10.1089/thy.2012.000522827552Search in Google Scholar

38. Wu HB, Wang QS, Wang MF, Li HS. Utility of ¹¹C-choline imaging as a supplement to F-18 FDG PET imaging for detection of thyroid carcinoma. Clin Nucl Med 2011; 36: 91-5.10.1097/RLU.0b013e318203bb5521220968Search in Google Scholar

39. Hodolic M, Michaud L, Huchet V, Balogova S, Nataf V, Kerrou K, et al. Consequence of the introduction of routine FCH PET/CT imaging in patients with prostate cancer: a dual centre survey. Radiol Oncol 2014; 48: 20-8. 10.2478/raon-2013-0049390884324587775Search in Google Scholar